Clinical Trial Update: Eicosapentaenoic Acid (EPA) for Treatment of Colorectal Cancer Liver Metastases [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Eicosapentaenoic acid (EPA) for the treatment of colorectal cancer liver metastases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Eicosapentaenoic acid (eicosapentaenoic acid)

Snippet

Sponsor: University of Leeds | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED